UH Medical School: Phase 1b study announced of NP001 in patients with mild-to-moderate Alzheimer’s Disease

Pictured: The University of Hawaiʻi Clinics at Kakaʻako SAN BRUNO, Calif. and HONOLULU, Sept. 13, 2017 — A clinical trial will begin soon on a drug that researchers hope will reduce inflammation in patients with Alzheimer’s Disease. The University of Hawai’i (UH) John A. Burns School of Medicine (JABSOM) will recruit 14 people, seven of … Continue reading UH Medical School: Phase 1b study announced of NP001 in patients with mild-to-moderate Alzheimer’s Disease